Literature DB >> 17576821

Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway.

William A Altemeier1, Xiaodong Zhu, William R Berrington, John M Harlan, W Conrad Liles.   

Abstract

Activation of the prototypical death receptor, Fas (CD95), can induce both caspase-dependent cell death and production of proinflammatory chemokines, leading to neutrophil recruitment and end-organ injury. The precise mechanism(s) by which Fas up-regulates chemokine production and release, is currently unclear. We hypothesized that Fas-induced chemokine release by macrophages is dependent on the MyD88 adaptor molecule and independent of caspase activity. To test this hypothesis, we measured chemokine response to Fas activation both in RAW 264.7 cells with RNAi-attenuated MyD88 expression and in MyD88-deficient primary macrophages. We found that Fas-induced chemokine release was abrogated in the absence of MyD88. In vivo, MyD88(-/-) mice had impaired CXCL1/KC release and polymorphonuclear cell recruitment in response to intratracheal treatment with the Fas-activating monoclonal antibody, Jo-2. Furthermore, Fas-induced chemokine release was not dependent on either IL-1 receptor signaling or on caspase activity. We conclude that MyD88 plays an integral role in Fas-induced macrophage-mediated inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576821      PMCID: PMC4492281          DOI: 10.1189/jlb.1006652

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  39 in total

1.  Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo.

Authors:  Peiyee Lee; Masataka Sata; David J Lefer; Stephen M Factor; Kenneth Walsh; Richard N Kitsis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-10-31       Impact factor: 4.733

Review 2.  MyD88 as a bottle neck in Toll/IL-1 signaling.

Authors:  O Takeuchi; S Akira
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

3.  Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction.

Authors:  S M Kang; D B Schneider; Z Lin; D Hanahan; D A Dichek; P G Stock; S Baekkeskov
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

Review 4.  The TNF-TNF receptor system.

Authors:  Thomas Hehlgans; Daniela N Männel
Journal:  Biol Chem       Date:  2002-10       Impact factor: 3.915

5.  Roles of CXC chemokines and macrophages in the recruitment of inflammatory cells and tumor rejection induced by Fas/Apo-1 (CD95) ligand-expressing tumor.

Authors:  Motomu Shimizu; Takayuki Yoshimoto; Mayumi Sato; Junji Morimoto; Akio Matsuzawa; Yasutaka Takeda
Journal:  Int J Cancer       Date:  2005-05-10       Impact factor: 7.396

6.  Molecular characterization and modular analysis of human MyD88.

Authors:  G Hardiman; F L Rock; S Balasubramanian; R A Kastelein; J F Bazan
Journal:  Oncogene       Date:  1996-12-05       Impact factor: 9.867

7.  Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens.

Authors:  Kieren A Marr; S Arunmozhi Balajee; Thomas R Hawn; Adrian Ozinsky; Uyenvy Pham; Shizuo Akira; Alan Aderem; W Conrad Liles
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function.

Authors:  A Ponton; M V Clément; I Stamenkovic
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

9.  Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.

Authors:  Yiwen Li; Genzou Takemura; Ken-ichiro Kosai; Tomoyuki Takahashi; Hideshi Okada; Shusaku Miyata; Kentaro Yuge; Satoshi Nagano; Masayasu Esaki; Ngin Cin Khai; Kazuko Goto; Atsushi Mikami; Rumi Maruyama; Shinya Minatoguchi; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Circ Res       Date:  2004-08-05       Impact factor: 17.367

10.  The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation.

Authors:  Alexander Golks; Dirk Brenner; Peter H Krammer; Inna N Lavrik
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

View more
  22 in total

1.  Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation.

Authors:  Purvi Mande; Bahar Zirak; Wei-Che Ko; Keyon Taravati; Karen L Bride; Tia Y Brodeur; April Deng; Karen Dresser; Zhaozhao Jiang; Rachel Ettinger; Katherine A Fitzgerald; Michael D Rosenblum; John E Harris; Ann Marshak-Rothstein
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

2.  Lung pericyte-like cells are functional interstitial immune sentinel cells.

Authors:  Chi F Hung; Kristen L Mittelsteadt; Rena Brauer; Bonnie L McKinney; Teal S Hallstrand; William C Parks; Peter Chen; Lynn M Schnapp; W Conrad Liles; Jeremy S Duffield; William A Altemeier
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-10       Impact factor: 5.464

3.  Genetic variation in the FAS gene and associations with acute lung injury.

Authors:  Bradford J Glavan; Tarah D Holden; Christopher H Goss; R Anthony Black; Margaret J Neff; Avery B Nathens; Thomas R Martin; Mark M Wurfel
Journal:  Am J Respir Crit Care Med       Date:  2010-09-02       Impact factor: 21.405

4.  Hematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state.

Authors:  R Angelo de Claro; Xiaodong Zhu; Jingjing Tang; Vicki Morgan-Stevenson; Barbara R Schwartz; Akiko Iwata; W Conrad Liles; Elaine W Raines; John M Harlan
Journal:  Am J Pathol       Date:  2011-05-06       Impact factor: 4.307

5.  Fas activation in alveolar epithelial cells induces KC (CXCL1) release by a MyD88-dependent mechanism.

Authors:  Alex W Farnand; Alison J Eastman; Raquel Herrero; Josiah F Hanson; Steve Mongovin; William A Altemeier; Gustavo Matute-Bello
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-21       Impact factor: 6.914

6.  Role of the Fas pathway in Pseudomonas aeruginosa keratitis.

Authors:  Zimei Zhou; Minhao Wu; Ronald P Barrett; Sharon A McClellan; Yunfan Zhang; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

7.  Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages.

Authors:  Feng Wang; Ziyue Lu; Michael Hawkes; Huan Yang; Kevin C Kain; W Conrad Liles
Journal:  J Inflamm (Lond)       Date:  2010-06-17       Impact factor: 4.981

8.  Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase.

Authors:  Kellie Burnside; Annalisa Lembo; Melissa de Los Reyes; Anton Iliuk; Nguyen-Thao Binhtran; James E Connelly; Wan-Jung Lin; Byron Z Schmidt; Anthony R Richardson; Ferric C Fang; Weiguo Andy Tao; Lakshmi Rajagopal
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

9.  MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection.

Authors:  Adeeb H Rahman; Weiguo Cui; David F Larosa; Devon K Taylor; Jidong Zhang; Daniel R Goldstein; E John Wherry; Susan M Kaech; Laurence A Turka
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.

Authors:  Lukas Bossaller; Vijay A K Rathinam; Ramon Bonegio; Ping-I Chiang; Patricia Busto; Adam R Wespiser; Daniel R Caffrey; Quan-Zhen Li; Chandra Mohan; Katherine A Fitzgerald; Eicke Latz; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.